GoodRx Holdings (GDRX) EBT (2019 - 2026)

GoodRx Holdings has disclosed EBT across 8 years of filings, most recently posting $15.5 million for Q2 2026.

• In Q2 2026, EBT fell 21.0% year-over-year to $15.5 million; the TTM figure through Jun 2026 stood at $41.4 million (down 25.76% YoY), while the FY2025 annual figure was $56.5 million, up 79.71% from the prior year.
• EBT came in at $15.5 million for Q2 2026 at GoodRx Holdings, up from $5.6 million in the prior quarter.
• In the past five years, EBT ranged from a high of $19.6 million in Q2 2025 to a low of -$46.6 million in Q3 2023.
• Average EBT over 5 years is $1.7 million, with a median of $7.1 million recorded in 2024.
• Year-over-year, EBT slumped 2154.52% in 2022 and jumped 5588.74% in 2025.
• Over 5 years, EBT stood at -$4.7 million in 2022, then sank by 419.18% to -$24.6 million in 2023, then jumped by 146.31% to $11.4 million in 2024, then rose by 24.4% to $14.2 million in 2025, then climbed by 8.97% to $15.5 million in 2026.
• Per Business Quant data, the three most recent EBT figures were $15.5 million in Q2 2026, $5.6 million in Q1 2026, and $14.2 million in Q4 2025.